HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
10.39
+0.34 (3.38%)
May 14, 2025, 9:49 AM - Market open
HCW Biologics Employees
HCW Biologics had 36 employees as of December 31, 2024. The number of employees decreased by 9 or -20.00% compared to the previous year.
Employees
36
Change (1Y)
-9
Growth (1Y)
-20.00%
Revenue / Employee
$71,300
Profits / Employee
-$833,995
Market Cap
11.67M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Dec 31, 2020 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HCWB News
- 13 hours ago - HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - GlobeNewsWire
- 1 day ago - HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization - GlobeNewsWire
- 6 weeks ago - HCW Biologics Announces 1-for-40 Reverse Stock Split - GlobeNewsWire
- 6 weeks ago - HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - GlobeNewsWire
- 2 months ago - HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements - GlobeNewsWire
- 3 months ago - HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - GlobeNewsWire
- 4 months ago - HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 - GlobeNewsWire
- 5 months ago - HCW Biologics Inc. Received NASDAQ Staff Determination Letter - GlobeNewsWire